AIMS: We investigate the role of mitochondrial oxidative stress in mitochondrial proteome remodelling using mouse models of heart failure induced by pressure overload. METHODS AND RESULTS: We demonstrate that mice overexpressing catalase targeted to mitochondria (mCAT) attenuate pressure overload-induced heart failure. An improved method of label-free unbiased analysis of the mitochondrial proteome was applied to the mouse model of heart failure induced by transverse aortic constriction (TAC). A total of 425 mitochondrial proteins were compared between wild-type and mCAT mice receiving TAC or sham surgery. The changes in the mitochondrial proteome in heart failure included decreased abundance of proteins involved in fatty acid metabolism, an increased abundance of proteins in glycolysis, apoptosis, mitochondrial unfolded protein response and proteolysis, transcription and translational control, and developmental processes as well as responses to stimuli. Overexpression of mCAT better preserved proteins involved in fatty acid metabolism and attenuated the increases in apoptotic and proteolytic enzymes. Interestingly, gene ontology analysis also showed that monosaccharide metabolic processes and protein folding/proteolysis were only overrepresented in mCAT but not in wild-type mice in response to TAC. CONCLUSION: This is the first study to demonstrate that scavenging mitochondrial reactive oxygen species (ROS) by mCAT not only attenuates most of the mitochondrial proteome changes in heart failure, but also induces a subset of unique alterations. These changes represent processes that are adaptive to the increased work and metabolic requirements of pressure overload, but which are normally inhibited by overproduction of mitochondrial ROS.
AIMS: We investigate the role of mitochondrial oxidative stress in mitochondrial proteome remodelling using mouse models of heart failure induced by pressure overload. METHODS AND RESULTS: We demonstrate that mice overexpressing catalase targeted to mitochondria (mCAT) attenuate pressure overload-induced heart failure. An improved method of label-free unbiased analysis of the mitochondrial proteome was applied to the mouse model of heart failure induced by transverse aortic constriction (TAC). A total of 425 mitochondrial proteins were compared between wild-type and mCATmice receiving TAC or sham surgery. The changes in the mitochondrial proteome in heart failure included decreased abundance of proteins involved in fatty acid metabolism, an increased abundance of proteins in glycolysis, apoptosis, mitochondrial unfolded protein response and proteolysis, transcription and translational control, and developmental processes as well as responses to stimuli. Overexpression of mCAT better preserved proteins involved in fatty acid metabolism and attenuated the increases in apoptotic and proteolytic enzymes. Interestingly, gene ontology analysis also showed that monosaccharide metabolic processes and protein folding/proteolysis were only overrepresented in mCAT but not in wild-type mice in response to TAC. CONCLUSION: This is the first study to demonstrate that scavenging mitochondrial reactive oxygen species (ROS) by mCAT not only attenuates most of the mitochondrial proteome changes in heart failure, but also induces a subset of unique alterations. These changes represent processes that are adaptive to the increased work and metabolic requirements of pressure overload, but which are normally inhibited by overproduction of mitochondrial ROS.
Authors: Jun Zhang; Xiaohai Li; Michael Mueller; Yueju Wang; Chenggong Zong; Ning Deng; Thomas M Vondriska; David A Liem; Jeong-In Yang; Paavo Korge; Henry Honda; James N Weiss; Rolf Apweiler; Peipei Ping Journal: Proteomics Date: 2008-04 Impact factor: 3.984
Authors: Mia Jüllig; Anthony J R Hickey; Chau C Chai; Gretchen L Skea; Martin J Middleditch; Silvana Costa; Soon Y Choong; Anthony R J Philips; Garth J S Cooper Journal: Proteomics Date: 2008-06 Impact factor: 3.984
Authors: Gary D Lopaschuk; John R Ussher; Clifford D L Folmes; Jagdip S Jaswal; William C Stanley Journal: Physiol Rev Date: 2010-01 Impact factor: 37.312
Authors: Dao-Fu Dai; Luis F Santana; Marc Vermulst; Daniela M Tomazela; Mary J Emond; Michael J MacCoss; Katherine Gollahon; George M Martin; Lawrence A Loeb; Warren C Ladiges; Peter S Rabinovitch Journal: Circulation Date: 2009-05-18 Impact factor: 29.690
Authors: Yuri Kim; Dillon Phan; Eva van Rooij; Da-Zhi Wang; John McAnally; Xiaoxia Qi; James A Richardson; Joseph A Hill; Rhonda Bassel-Duby; Eric N Olson Journal: J Clin Invest Date: 2008-01 Impact factor: 14.808
Authors: Heiko Bugger; Michael Schwarzer; Dong Chen; Andrea Schrepper; Paulo A Amorim; Maria Schoepe; T Dung Nguyen; Friedrich W Mohr; Oleh Khalimonchuk; Bart C Weimer; Torsten Doenst Journal: Cardiovasc Res Date: 2009-10-19 Impact factor: 10.787
Authors: Michael Schwarzer; Moritz Osterholt; Anne Lunkenbein; Andrea Schrepper; Paulo Amorim; Torsten Doenst Journal: J Physiol Date: 2014-06-20 Impact factor: 5.182
Authors: Aly Elezaby; Aaron L Sverdlov; Vivian H Tu; Kanupriya Soni; Ivan Luptak; Fuzhong Qin; Marc Liesa; Orian S Shirihai; Jamie Rimer; Jean E Schaffer; Wilson S Colucci; Edward J Miller Journal: J Mol Cell Cardiol Date: 2014-12-09 Impact factor: 5.000
Authors: Kadambari Chandra Shekar; Ling Li; Erinne R Dabkowski; Wenhong Xu; Rogerio Faustino Ribeiro; Peter A Hecker; Fabio A Recchia; Rovshan G Sadygov; Belinda Willard; Takhar Kasumov; William C Stanley Journal: J Mol Cell Cardiol Date: 2014-07-01 Impact factor: 5.000